dc.contributor.author
Lantero, Elena
dc.contributor.author
Belavilas Trovas, Alexandros
dc.contributor.author
Biosca, Arnau
dc.contributor.author
Recolons, Paula
dc.contributor.author
Moles Meler, Ernest
dc.contributor.author
Sulleiro, Elena
dc.contributor.author
Zarzuela, Francesc
dc.contributor.author
Avalos Padilla, Yunuen
dc.contributor.author
Ramírez, Miriam
dc.contributor.author
Fernàndez Busquets, Xavier
dc.date.issued
2022-04-19T12:25:10Z
dc.date.issued
2022-04-19T12:25:10Z
dc.date.issued
2020-03-01
dc.date.issued
2022-04-08T18:00:43Z
dc.identifier
https://hdl.handle.net/2445/185018
dc.description.abstract
"New biomarkers have to be developed in order to increase the performance of current antigen-based malaria rapid diagnosis. Antibody production often involves the use of laboratory animals and is time-consuming and costly, especially when the target is " - ", whose variable antigen expression
complicates the development of long-lived biomarkers. To
circumvent these obstacles, we have applied the Systematic
Evolution of Ligands by EXponential enrichment method to the
rapid identification of DNA aptamers against " - "-infected red
blood cells (pRBCs). Five 70 b-long ssDNA sequences, and their
shorter forms without the flanking PCR primer-binding regions,
have been identified having a highly specific binding of pRBCs
versus non-infected erythrocytes. Structural analysis revealed
G-enriched sequences compatible with the formation of
G-quadruplexes. The selected aptamers recognized intracellular
epitopes with apparent " - "s in the " - "M range in both fixed
and non-fixed saponin-permeabilized pRBCs, improving
>30-fold the pRBC detection in comparison with aptamers
raised against " - " lactate dehydrogenase, the gold standard
antigen for current malaria diagnostic tests. In thin blood
smears of clinical samples the aptamers reported in this work
specifically bound all " - " stages versus non-infected
erythrocytes, and also detected early and late stages of the
human malaria parasites " - ", " - " and " - . The results are
discussed in the context of their potential application in
future malaria diagnostic devices.
dc.format
application/pdf
dc.format
application/pdf
dc.publisher
American Scientific Publishers
dc.relation
Postprint del document publicat a: http://dx.doi.org/10.1166/jbn.2020.2901
dc.relation
Journal of biomedical nanotechnology, 2020, vol. 16, num. 3, p. 315-334
dc.relation
http://dx.doi.org/10.1166/jbn.2020.2901
dc.rights
(c) American Scientific Publishers, 2020
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (ISGlobal)
dc.subject
Nanotecnologia
dc.subject
Nanotechnology
dc.title
Development of DNA Aptamers Against <i>Plasmodium falciparum</i> Blood Stages Using Cell-Systematic Evolution of Ligands by EXponential Enrichment.
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion